Article Text
Abstract
The costs of whole-genome sequencing have rapidly decreased, and it is being increasingly deployed in large-scale clinical research projects and introduced into routine clinical care. This will lead to rapid diagnoses for patients with genetic disease but also introduces uncertainty because of the diversity of human genomes and the potential difficulties in annotating new genetic variants for individual patients and families. Here we outline the steps in organising whole-genome sequencing for patients in the neurology clinic and emphasise that close liaison between the clinician and the laboratory is essential.
- neurogenetics
Statistics from Altmetric.com
Footnotes
Twitter @huwmorris
Contributors HM wrote the article. HH and JP reviewed, commented and provided critical intellectual input.
Funding We acknowledge funding from Medical Research Council (G1100643) and Parkinson’s UK (K1501).
Competing interests HM is employed by UCL. In the last 24 months; he reports paid consultancy from Biogen, Biohaven and Lundbeck; lecture fees/honoraria from Wellcome Trust, Movement Disorders Society; research Grants from Parkinson’s UK, Cure Parkinson’s Trust, PSP Association, CBD Solutions, Drake Foundation and Medical Research Council. HM is a coapplicant on a patent application related to C9ORF72 - Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140).
Provenance and peer review Not commissioned; externally peer reviewed by Simon Hammans, Southampton, UK, and Mark Manford, Cambridge, UK.
Linked Articles
- Editors’ commentary
Read the full text or download the PDF:
Other content recommended for you
- Gene panel for Mendelian strokes
- Epilepsy genetics: a practical guide for adult neurologists
- Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
- Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
- EyeG2P: an automated variant filtering approach improves efficiency of diagnostic genomic testing for inherited ophthalmic disorders
- Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study
- Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes Project
- Genetics of hypertrophic cardiomyopathy: what is the next step?
- Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues
- Rare MYC-N11S germline mutation indicative of inherited breast cancer in a multigeneration family